Clinical Trial Update: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated pyridoxine (vitamin B6) in preventing hand-foot syndrome in patients treated with liposomal doxorubicin for several cancers; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pyridoxine (Pyridoxine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer, Drug/Agent Toxicity by Tissue/Organ | Phase 3 | Status: COMPLETED | Results posted: 2010-12-22